02 Records
FEED: ACQUIRING
01 RecordSTATE: PUBLISHED
02 Description
CNA: BaxterImproper Access Control Vulnerability in ELI Electrocardiograph Devices
03 Exploitation and scoring
SRC: CISA, FIRST, NVD, RED HAT- Exploitation
- Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.
- SSVC decision
- ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
- AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
- Technical ImpactpartialSuccessful exploitation gives limited control of the vulnerable component.
CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.- EPSS probability
- 0.29% probability of exploitation activity in the next 30 days.
- EPSS percentile
- Ranks above 21.0% of scored records. A rank, not a probability.
- NVD base score
- 7.7 (CVSS v3.x), scored by the NVD independently of the CNA.
- NVD CVSS vector
- CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H
- NVD analysis status
- Deferred. NVD last modified this record on 2026-06-17.
- Red Hat severity
- No Red Hat rating. Red Hat rates the CVEs that affect its products.
Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.
SCHEMA: 5.1
- Published
- 2025-02-07 17:07Z1 YR AGO
- Last updated
- 2025-02-07 18:49Z1 YR AGO
- Reserved
- 2022-03-03
- Assigning CNA
- Baxter
- Record state
- PUBLISHED
- Severity
- High (CVSS 7.7)
- CNA CVSS vector
- CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H
- Weaknesses
- CWE-284Improper Access ControlPillar
- Data version
- 5.1
- Document digest
- 18a0e4739533a69852b369ae6370b04acc4803c74d48c97310ed5f02ed1c9932
05 Affected products
PAIRS: 4VendorProductVersionsPlatforms
SRC: CNA
Hillrom has released software updates for all impacted devices to
address these vulnerabilities. New product versions that mitigate these
vulnerabilities are available as follows:
* Welch Allyn ELI 380 Resting Electrocardiograph: available Q4 2023
* Welch Allyn ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: available May 2022
* Welch Allyn ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: available Q4 2023
Hillrom recommends users upgrade to the latest product versions.
Information on how to update these products can be found on the Hillrom disclosure page https://hillrom.com/en/responsible-disclosures/
.